Your search returned 3 results.

Results
	1.	[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)--evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group]. [electronic resource] by Kimijima, Izo Tominaga, Takeshi Nomizu, Tadashi Nomura, Yasuo Takashima, Shigemitsu Koyama, Hiroki Sano, Muneaki Tohge, Tetsuya Ueo, Hiroaki Ikeda, Seiyo Ohashi, Yasuo Producer: 20020611 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	2.	[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study for postmenopausal women with advanced or recurrent breast cancer (no. 1)--investigation of recommended clinical dose CGS20267 Study Group]. [electronic resource] by Abe, Rikiya Tominaga, Takeshi Nomizu, Tadashi Nomura, Yasuo Takashima, Shigemitsu Koyama, Hiroki Sano, Muneaki Tohge, Tetsuya Ueo, Hiroaki Ikeda, Seiyo Ohashi, Yasuo Producer: 20020611 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	3.	[CGS 20267 (Letrozole), a new aromatase inhibitor: early phase II study for postmenopausal women with advanced breast cancer]. [electronic resource] by Nomura, Yasuo Tominaga, Takeshi Enomoto, Kouji Aoyama, Hideaki Nakamura, Yasuya Abe, Rikiya Sano, Muneaki Nomizu, Tadashi Tohge, Tetsuya Takashima, Shigemitsu Ohashi, Yasuo Producer: 20020516 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 29 Availability: No items available. Save to lists Add to cart (remove)